brl-28500 and Pulmonary-Aspergillosis

brl-28500 has been researched along with Pulmonary-Aspergillosis* in 1 studies

Other Studies

1 other study(ies) available for brl-28500 and Pulmonary-Aspergillosis

ArticleYear
    Thorax, 2019, Volume: 74, Issue:8

    While. To determine the risk and explanatory factors of acquiring. Cross-sectional analysis of clinical, bronchoalveolar lavage and treatment data from the Australasian Cystic Fibrosis Bronchoalveolar Lavage study was used to identify predictive factors for detecting. Cross-sectional analysis found that the number of. In young children with CF, completing

    Topics: Anti-Bacterial Agents; Bronchoalveolar Lavage; Ceftazidime; Child, Preschool; Ciprofloxacin; Clavulanic Acids; Cross-Sectional Studies; Cystic Fibrosis; Female; Humans; Infant; Longitudinal Studies; Male; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Pulmonary Aspergillosis; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Ticarcillin; Tobramycin

2019